Sickle cell disease Transfusion therapy is used as an emergency procedure to treat life-threatening complications of
sickle-cell disease as well as an elective procedure to stop these complications occurring. • Mesenteric girdle syndrome • To optimise hemoglobin S levels, for example to prevent a stroke occurring in a child. Polycythemia can occur in neonates for multiple different reasons including: babies born after 42 weeks gestation (post-term), babies born to diabetic mothers,
twin to twin transfusion,
intrauterine growth restriction, and babies with genetic abnormalities. but there is no evidence that it prevents long-term complications. However, in 2013 the CDC examined the limited evidence available and found no evidence that exchange transfusion has any beneficial effects (decreased mortality) in people with very high parasite loads (> 10%). Also, although uncommon, exchange transfusion can cause complications (low blood pressure (
hypotension), abnormal heart rhythms (
ventricular fibrillation) and breathing problems (
acute respiratory distress syndrome)). Based on this evidence, the CDC no longer recommend the use of exchange transfusion in the treatment of malaria. ==Risks==